Glucocorticoids With Antihistamines Versus Antihistamines in Acute Urticaria in Emergency
NCT02565680 · Status: COMPLETED · Phase: PHASE2/PHASE3 · Type: INTERVENTIONAL · Enrollment: 100
Last updated 2023-05-23
Summary
Acute urticaria is common and affected 12% of population. 400 patients come in department emergency of Toulouse each year and there aren't many studies in literature which evaluate the glucocorticoids treatment. The standard treatment of urticaria is antihistamines H1, but glucocorticoids treatment administered orally for short course would permit to increase quickly acute urticaria uncomplicated. Clinical trial, prospective randomized double blinded of adults with acute urticaria less 24 hours duration and no take treatment urticaria before.
Conditions
- Acute Urticaria
Interventions
- DRUG
-
Xyzall 5mg during 5 days + placebo 40mg during 4 days
- DRUG
-
Xyzall 5mg during 5 days + prednisone 40mg during 4 days
Sponsors & Collaborators
-
University Hospital, Toulouse
lead OTHER
Principal Investigators
-
Caroline Barniol, MD · University Hospital, Toulouse
Study Design
- Allocation
- RANDOMIZED
- Purpose
- TREATMENT
- Masking
- DOUBLE
- Model
- PARALLEL
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2012-02-29
- Primary Completion
- 2014-02-28
- Completion
- 2014-02-28
Countries
- France
Study Locations
More Related Trials
-
Efficacy of Antihistamine Dosing-up and add-on Treatment With H2-receptor Antagonist
NCT03293225 ·Status: COMPLETED
-
Study to Assess the Safety, Tolerability, Pharmacokinetics and Immunogenicity of AK006 in Healthy Subjects and Subjects With Chronic Spontaneous Urticaria
NCT06072157 ·Status: COMPLETED ·Phase: PHASE1
-
An Efficacy and Safety Study of Desloratadine (MK-4117) in Japanese Participants With Chronic Urticaria (MK-4117-201)
NCT01916967 ·Status: COMPLETED ·Phase: PHASE3
-
Frequency of Parasite Infestation in Patients With Chronic Spontaneous Urticaria
NCT04314999 ·Status: COMPLETED
-
Dietary Treatment for Chronic Urticaria
NCT02047136 ·Status: TERMINATED ·Phase: NA
-
Efficacy and Safety of Lertal® as an add-on to Standard Therapy for Allergic Rhinoconjunctivitis in Pediatrics
NCT03365648 ·Status: COMPLETED ·Phase: NA
-
Levocetirizine Plus Bed-Time Hydroxyzine in the Management of Corticodependent Chronic Urticaria Versus Levocetirizine Alone in High Doses
NCT01250652 ·Status: COMPLETED ·Phase: PHASE4
-
Antiplatelet Therapy in Chronic Urticaria
NCT06268470 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE2
-
A Study of Efficacy and Safety of TLL-018 in CSU Participants
NCT06396026 ·Status: RECRUITING ·Phase: PHASE3
-
Safety Study of Levocetirizine Dihydrochloride Oral Liquid Formulation in Children Aged 6 Months to 11 Months
NCT00628108 ·Status: COMPLETED ·Phase: PHASE3
-
Evaluation of Treatment Satisfaction in Children With an Allergy and Who Received an Antihistamine
NCT00453583 ·Status: COMPLETED
-
Comparison of Desloratadine Associated With Prednisolone Oral Solution Versus Dexchlorpheniramine Associated With Betamethasone for Cutaneous Rash Treatment
NCT01529242 ·Status: TERMINATED ·Phase: PHASE3
-
Evaluation of the Inhibitory Effect of 5 Anti-Histamines in Urticaria
NCT01940393 ·Status: COMPLETED ·Phase: PHASE4
-
Study to Compare the Efficacy and Safety Between Levocetirizine and Loratadine for Chronic Idiopathic Urticaria
NCT00525382 ·Status: COMPLETED ·Phase: PHASE3
-
Validation of an Allergic Rhinitis Control Test in Teenagers
NCT02818153 ·Status: UNKNOWN ·Phase: NA
-
Treatment Options for Chronic Urticaria
NCT06816784 ·Status: NOT_YET_RECRUITING ·Phase: PHASE2
-
A Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Preliminary Efficacy of HS-10561 Capsule in Healthy Chinese Adults and Patients With Chronic Spontaneous Urticaria.
NCT06864507 ·Status: NOT_YET_RECRUITING ·Phase: PHASE1/PHASE2
-
Efficacy and Safety of Omalizumab in Adults (18-70 Years) With Moderate to Severe Chronic Urticaria
NCT00481676 ·Status: COMPLETED ·Phase: PHASE2
-
Study In Adults And Adolescents With Seasonal Allergic Rhinitis.
NCT00225823 ·Status: COMPLETED ·Phase: PHASE3
-
Management of Drug Hypersensitivity in Children
NCT02031120 ·Status: TERMINATED
-
Safety Study of Levocetirizine and Fexofenadine
NCT01586091 ·Status: COMPLETED ·Phase: PHASE4
-
An Outpatient Study of the Efficacy of ARS-2 in Patients With Chronic Spontaneous Urticaria
NCT06927999 ·Status: RECRUITING ·Phase: PHASE2
-
Study to Investigate the Safety and Efficacy of Alesion® in Japanese Paediatric Patients With Urticaria
NCT02238249 ·Status: COMPLETED
-
The Diagnosis of Oral Allergy Syndrome Through the Use of a Structured Questionnaire
NCT00854958 ·Status: COMPLETED
-
Study In Adolescent And Adult Subjects 12 Years Of Age And Older With Seasonal Allergic Rhinitis To Assess Onset of Action
NCT00118729 ·Status: COMPLETED ·Phase: PHASE3